ORLANDO, Fla. & SADDLE BROOK, N.J.--(BUSINESS WIRE)--CircuLite, Inc. today announced the presentation of positive clinical data for its Synergy® Pocket Micro-pump for chronic heart failure. The data demonstrates that long-term, partial circulatory support with Synergy yielded statistically significant hemodynamic benefits and sustained improvements in cardiac function with evidence of myocardial recovery in patients with chronic heart failure. The presentation was given by Daniel Burkhoff, M.D., Ph.D., Chief Medical Officer of CircuLite and Adjunct Associate Professor of Medicine at Columbia University Medical School, at the 58th Annual Scientific Session of the American College of Cardiology in the Late-Breaking Clinical Trials Emerging Technologies session. Synergy is a micro-blood pump, the size of a AA battery, that can be implanted superficially in a “pacemaker-like” pocket. Synergy is the first and smallest device designed for partial circulatory support (up to 3L/min) and long-term use in patients with Class IIIb and early Class IV heart failure.
